Lenz S, Lindenberg S, Sundberg K, Hamberger L, Sjögren A
Department of Obstetrics and Gynecology, Rigshospitalet, University of Copenhagen, Denmark.
J In Vitro Fert Embryo Transf. 1991 Oct;8(5):265-71. doi: 10.1007/BF01139782.
In order to obtain incubation in uteri of spermatozoa, oocytes, and embryos, for treatment of patients referred for in vitro fertilization, a capsule was produced which could contain the human gametes and allow human fertilization and embryo growth after intrauterine introduction. Agar was chosen for capsule material and a mold was constructed for the production of capsules. The material was tested in vitro using mouse embryos and human oocytes and sperm. Intrauterine resolution was tested on mice and by insertion on 11 women. Empty capsules were inserted into the uterine cavity in 15 cycles the day after the luteinizing hormone peak and followed by daily ultrasound examinations. The resolution time was adjusted by changing the wall thickness of the capsules. The final type was dissolved after 3 to 4 days. No complications were observed and capsules could be inserted on all occasions. The major problem was expelling of capsules, which occurred in seven cycles. The problem seemed to be solved by the administration of indomethacin at the day of insertion.
为了获得精子、卵母细胞和胚胎的子宫内孵育,用于治疗接受体外受精的患者,制作了一种胶囊,该胶囊可容纳人类配子,并在子宫内植入后实现人类受精和胚胎发育。选择琼脂作为胶囊材料,并构建了用于生产胶囊的模具。使用小鼠胚胎以及人类卵母细胞和精子对该材料进行了体外测试。在小鼠身上以及通过对11名女性进行植入来测试子宫内的降解情况。在黄体生成素峰值后的第1天,将空胶囊插入15个周期的子宫腔中,随后每天进行超声检查。通过改变胶囊的壁厚来调整降解时间。最终类型在3至4天后溶解。未观察到并发症,并且在所有情况下都可以插入胶囊。主要问题是胶囊排出,这发生在7个周期中。在插入当天给予吲哚美辛似乎解决了这个问题。